Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Elys Game Technology Corp

Start price
Target price
Perf. (%)
€2.04
28.11.20
-
28.11.21
68.30%
19.11.21

Could be very worthwhile Investment >20% year
Nordex SE

Start price
Target price
Perf. (%)
€17.72
18.11.20
-
18.11.21
-14.50%
19.11.21

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
MagForce AG

Start price
Target price
Perf. (%)
€3.01
18.11.20
€4.00
18.11.21
12.29%
19.11.21

Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.25
17.11.21
€37.50
30.11.22
-19.46%
18.11.21

Could be very worthwhile Investment >20% year
buy
Powercell Sweden AB

Start price
Target price
Perf. (%)
€20.25
10.07.21
-
10.07.22
17.23%
18.11.21

Below average Marketposition
Business model of the past or high risk
Risky Investment
Artprice.com

Start price
Target price
Perf. (%)
€21.65
15.11.21
-
15.11.22
-22.68%
18.11.21

Probably not worthwhile Investment
buy
Northern Data AG

Start price
Target price
Perf. (%)
€77.30
11.07.21
€180.00
11.07.22
26.78%
18.11.21

Could be worthwhile Investment >10% per year
Undervalued
Standard Investments for future growth
Normal challenges to pay loans and raise capital
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.19
11.11.21
-
11.11.22
2.28%
17.11.21

Could be worthwhile Investment >10% per year
buy
Kintara Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
16.11.20
€1.00
16.11.21
-45.11%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
CBAK Energy Technology Inc

Start price
Target price
Perf. (%)
€7.65
16.11.20
€2.00
16.11.21
-75.16%
17.11.21

Probably not worthwhile Investment
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€9.04
14.11.21
€4.50
31.12.23
-21.76%
16.11.21

Could be very worthwhile Investment >20% year
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€27.09
18.10.21
-
18.10.25
37.70%
16.11.21

Could be worthwhile Investment >10% per year
buy
The Exone Company

Start price
Target price
Perf. (%)
€15.59
08.07.21
-
08.07.22
49.71%
16.11.21

buy
Overstock.com

Start price
Target price
Perf. (%)
€59.04
23.08.21
-
23.08.22
57.52%
16.11.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
buy
Catalyst Biosciences Inc

Start price
Target price
Perf. (%)
€0.89
12.11.21
-
12.11.22
-14.69%
15.11.21

Risky Investment
Esker S.A.

Start price
Target price
Perf. (%)
€285.00
17.09.21
€285.00
17.09.22
20.00%
15.11.21

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€148.30
04.10.21
-
04.10.22
2.14%
15.11.21

Could be worthwhile Investment >10% per year
Some uniques
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€2.60
31.10.21
-
31.10.22
5.00%
14.11.21

Risky Investment
buy
Orphazyme A/S

Start price
Target price
Perf. (%)
€3.88
01.11.21
-
01.11.22
-13.92%
14.11.21

Risky Investment
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€2.40
12.11.21
-
12.11.22
-20.42%
14.11.21

Risky Investment
buy
MBB SE

Start price
Target price
Perf. (%)
€139.00
01.11.21
€155.00
01.11.22
-0.86%
14.11.21

Standard Investments for future growth
Differentiated customer and product portfolio
Higher risks for its business
Significant cyclical dependencies
buy
OceanaGold Corp.

Start price
Target price
Perf. (%)
€1.20
13.11.20
€2.00
13.11.21
60.00%
14.11.21

Could be very worthwhile Investment >20% year
buy
Manz AG

Start price
Target price
Perf. (%)
€44.15
02.11.21
-
02.11.22
12.23%
13.11.21

Could be worthwhile Investment >10% per year